SCHEMBL12366391

SCHEMBL12366391

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccc(Cl)cc2C)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
RXRA P19793 3/20 0.39
NR1H2 P55055 3/20 0.39
NR1H3 Q13133 3/20 0.39
HPGD P15428 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CNR1 P21554 1/20 0.38
MAPT P10636 2/20 0.36
PPARG P37231 2/20 0.36
POLQ O75417 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
CNR2 P34972 1/20 0.34
TP53 P04637 2/20 0.33
C5AR1 P21730 1/20 0.33
DDR1 Q08345 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366413 0.91 NR1H2 (0.36) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366303 0.90 NR1H2 (0.40) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366427 0.90 ALDH1A1 (0.51) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366218 0.89 ALDH1A1 (0.41) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366320 0.85 KDM4E (0.47) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366315 0.84 ALDH1A1 (0.48) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366437 0.84 RXRA (0.38) ALDH1A1RXRANR1H2NR1H3CNR1
SCHEMBL12366432 0.84 RXRA (0.38) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366459 0.83 KDM4E (0.43) KDM4EALDH1A1RXRANR1H2NR1H3
SCHEMBL12366818 0.83 NR1H2 (0.49) KDM4EALDH1A1RXRANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed